Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-211 Cr₹-247 Cr₹-363 Cr₹35 Cr₹-186 Cr

What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?

The latest Cash Flow from Financing Activities ratio of NATCO PHARMA is ₹-211 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-211 Cr
Mar2024₹-247 Cr
Mar2023₹-363 Cr
Mar2022₹35 Cr
Mar2021₹-186 Cr

How is Cash Flow from Financing Activities of NATCO PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-211 Cr
Negative
Mar2024 ₹-247 Cr
Negative
Mar2023 ₹-363 Cr
Negative
Mar2022 ₹35 Cr
Positive
Mar2021 ₹-186 Cr -

Compare Cash Flow from Financing Activities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,806.5 Cr 4.2% 2.6% -35.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,827.0 Cr -0.5% 1.8% -2% Stock Analytics
DIVIS LABORATORIES ₹163,363.0 Cr -0.3% -1.3% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,193.0 Cr 4.4% 6% 27.7% Stock Analytics
CIPLA ₹109,519.0 Cr 1% -3% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,940.0 Cr 1.1% 8% 3.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

4.2%

2.6%

-35.8%

SENSEX

-0.9%

-0.1%

7%


You may also like the below Video Courses